title: [Anomalous serological pattern of hepatitis B virus in 2 patients treated with alemtuzumab].
authors.affiliation: Tomás García Lozano, Servicio de Análisis Clínicos y Microbiología, Fundación Instituto Valenciano de Oncología, C/Gregorio Gea, 31, 46009, Valencia, Spain. tglmicro@gmail.com.
authors.forename: Tomás
authors.initials: T
authors.lastname: García-Lozano
authors.forename: Eduardo
authors.initials: E
authors.lastname: Aznar-Oroval
authors.forename: Ángel
authors.initials: Á
authors.lastname: Guerrero-Zotano
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000378:metabolism / Q000627:therapeutic use*; D015703:Antigens, CD / Q000378:metabolism; D000951:Antigens, Neoplasm / Q000378:metabolism; D000970:Antineoplastic Agents / Q000378:metabolism / Q000627:therapeutic use*; D000074301:CD52 Antigen; D002353:Carrier State; D004279:DNA, Viral / Q000235:genetics; D005260:Female; D006023:Glycoproteins / Q000378:metabolism; D006508:Hepatitis Antibodies / Q000032:analysis; D006509:Hepatitis B / Q000188:drug therapy* / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000235:genetics / Q000502:physiology*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications; D008228:Lymphoma, Non-Hodgkin / Q000150:complications; D009154:Mutation / Q000235:genetics; D014775:Virus Activation / Q000187:drug effects
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D015703:Antigens, CD; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D000074301:CD52 Antigen; C000613862:CD52 protein, human; D004279:DNA, Viral; D006023:Glycoproteins; D006508:Hepatitis Antibodies; D006514:Hepatitis B Surface Antigens; D000074323:Alemtuzumab